| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | -4,8 k € | -101.2% | 392,9 k € | +342.8% | -161,8 k € | -21.1% | -133,6 k € | |
| EBITDA | -105,2 k € | -126.8% | 392,5 k € | +342.0% | -162,2 k € | -21.1% | -133,9 k € | |
| Operating profit | -221,9 k € | -164.7% | 343,1 k € | +275.3% | -195,7 k € | -45.0% | -135,0 k € | |
| Profit/loss | -228,9 k € | -166.9% | 342,1 k € | +274.2% | -196,4 k € | -45.5% | -135,0 k € | |
| Equity | 473,6 k € | -32.6% | 702,5 k € | +829.9% | 75,5 k € | +4.9% | 72,0 k € | |
| Total assets | 794,5 k € | -18.1% | 970,3 k € | +343.7% | 218,7 k € | +72.1% | 127,1 k € | |
| Cash | 4,8 k € | -98.2% | 257,2 k € | +412.0% | 50,2 k € | +748.6% | 5,9 k € | |
| Debts | 320,9 k € | +19.8% | 267,8 k € | +87.1% | 143,1 k € | +159.8% | 55,1 k € | |
Private limited company · La Hulpe · incorporated on 16/03/2022
Private limited company loss-making in the latest fiscal year. Cash position declining (-98.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
YNIOS Pharma is a Private limited company incorporated in 2022. Its main activity is: Manufacture of perfumes and toilet preparations. Its registered office is in La Hulpe.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette